CFTR and cystic fibrosis: We report that fully differentiated CF bronchial epithelial cells treated with ETI in combination with a highly selective furin inhibitor, BOS-318, showed improved CFTR-mediated Cl− secretion and a concurrent reduction in ENaC-mediated Na+ absorption.